Wholesale of pharmaceutical and medical goods
MICRONOVA AS
Revenue 2024
NOK 593,000
Operating profit
NOK −53,000
Equity
NOK 335,000
Incorporated
2003
Share capital
NOK 100,000
Key figures · 2025
Current ratio
1.89
Equity ratio
47.1%
Key figures over time · 2025
| Key figures | 2025 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | -8.9% | |
| Net margin (%%) | -9.3% | |
| Return on assets (%%) | -7.4% | |
| Likviditet | ||
| Current ratio | 1.89 | |
| Working capital | 335k | |
| Soliditet | ||
| Equity ratio (%%) | 47.1% | |
| Debt-to-equity ratio | 1.12 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.